Clinical trial
Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function.
NCT06361732 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function.
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 17, 2022
- Completion date
- October 30, 2024
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pediatric liver transplant